Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs193922401
rs193922401
0.710 GeneticVariation BEFREE Here we investigate the molecular mechanism by which two heterozygous mutations in the second nucleotide-binding domain (NBD2) of SUR1 (R1380L and R1380C) separately cause neonatal diabetes. 18025464

2007

dbSNP: rs80356611
rs80356611
0.710 GeneticVariation BEFREE We identified a novel KCNJ11 mutation, R50Q, that causes permanent neonatal diabetes (PNDM) without neurological problems. 16731833

2006

dbSNP: rs80356624
rs80356624
0.030 GeneticVariation BEFREE We identified KCNJ11 mutations in four of 10 probands with permanent neonatal diabetes and one affected parent; this included the novel C166F mutation and the previously described V59M and R201H. 16670688

2006

dbSNP: rs80356624
rs80356624
0.030 GeneticVariation BEFREE Sulfonylurea treatment in a girl with neonatal diabetes (KCNJ11 R201H) and celiac disease: impact of low compliance to the gluten free diet. 19345438

2009

dbSNP: rs80356624
rs80356624
0.030 GeneticVariation BEFREE This is consistent with the ability of the R201H mutation to cause neonatal diabetes in patients. 17065345

2006

dbSNP: rs1285524167
rs1285524167
0.020 GeneticVariation BEFREE We report the response to sulfonylurea treatment in a boy with neonatal diabetes and marked developmental delay resulting from the KCNJ11 mutation V59M. 17047922

2006

dbSNP: rs1285524167
rs1285524167
0.020 GeneticVariation BEFREE Expression of the V59M Kir6.2 mutation in pancreatic beta cells alone is thus sufficient to recapitulate the neonatal diabetes observed in humans. beta-V59M islets also displayed a reduced percentage of beta cells, abnormal morphology, lower insulin content, and decreased expression of Kir6.2, SUR1, and insulin mRNA. 19065048

2009

dbSNP: rs193929337
rs193929337
0.020 GeneticVariation BEFREE Some mutations in this gene, including p.Q52R, are associated with the developmental delay, epilepsy, neonatal diabetes (DEND) syndrome. 24150202

2014

dbSNP: rs193929337
rs193929337
0.020 GeneticVariation BEFREE First case of neonatal diabetes with KCNJ11 Q52R mutation successfully switched from insulin to sulphonylurea treatment. 28083968

2017

dbSNP: rs587783673
rs587783673
0.020 GeneticVariation BEFREE Chromosomal microarray at 11 weeks of age showed XXY and a panel-based, molecular test for neonatal diabetes revealed a pathogenic heterozygous variant c.685G>A (p.Glu229Lys) in KCNJ11. 28766502

2018

dbSNP: rs587783673
rs587783673
0.020 GeneticVariation BEFREE Two cases of transient NDM in extremely preterm, 24 weeks' gestational age (GA) triplets, due to a missense mutation c.685G>A in the KCNJ11 gene are presented. 28350539

2017

dbSNP: rs80356616
rs80356616
0.020 GeneticVariation BEFREE We identified KCNJ11 mutations in four of 10 probands with permanent neonatal diabetes and one affected parent; this included the novel C166F mutation and the previously described V59M and R201H. 16670688

2006

dbSNP: rs80356616
rs80356616
0.020 GeneticVariation BEFREE We report the response to sulfonylurea treatment in a boy with neonatal diabetes and marked developmental delay resulting from the KCNJ11 mutation V59M. 17047922

2006

dbSNP: rs137852673
rs137852673
0.010 GeneticVariation BEFREE Here we investigate the molecular mechanism by which two heterozygous mutations in the second nucleotide-binding domain (NBD2) of SUR1 (R1380L and R1380C) separately cause neonatal diabetes. 18025464

2007

dbSNP: rs193922405
rs193922405
0.010 GeneticVariation BEFREE Two novel mutations (E1506D, E1506G) in the nucleotide-binding domain 2 (NBD2) of the ATP-sensitive K(+) channel (K(ATP) channel) sulfonylurea receptor 1 (SUR1) subunit were detected heterozygously in patients with neonatal diabetes. 21617188

2011

dbSNP: rs193929355
rs193929355
0.010 GeneticVariation BEFREE We assessed the functional effects of two Kir6.2 mutations associated with ND: K170T and E322K. 17919178

2007

dbSNP: rs193929373
rs193929373
0.010 GeneticVariation BEFREE To investigate the prevalence and clinical characteristics of heterozygotes of the glucokinase gene mutations G264S and IVS8+2 in the extended pedigree of two patients with permanent neonatal diabetes as a result of glucokinase deficiency (IVS8+2 homozygosity and IVS8+2/G264S compound heterozygosity). 16026363

2005

dbSNP: rs193929375
rs193929375
GCK
0.010 GeneticVariation BEFREE We describe a novel homozygous missense glucokinase mutation (R397L) resulting in insulin-treated neonatal diabetes in an infant from a consanguineous Asian family. 15644838

2005

dbSNP: rs534808921
rs534808921
0.010 GeneticVariation BEFREE A heterozygous mutation, c.125T>G (p. Val42Gly), was identified in a neonatal diabetes mellitus patient's INS gene. 29890547

2020

dbSNP: rs59852838
rs59852838
0.010 GeneticVariation BEFREE Overexpression of SUR1-Y356C in INS1(832/13) cells impaired glucose-induced cell depolarization and increased in intracellular free Ca(2+) concentration, albeit more weakly than neonatal diabetes-associated SUR1 mutants. 18346985

2008

dbSNP: rs758604661
rs758604661
0.010 GeneticVariation BEFREE We studied a male infant with compound heterozygous ABCC8 mutations (p.Arg826Trp/p.Ile93Thr) causing neonatal diabetes mellitus.He died of ketoacidosis. 24941889

2014

dbSNP: rs779736828
rs779736828
0.010 GeneticVariation BEFREE We studied a male infant with compound heterozygous ABCC8 mutations (p.Arg826Trp/p.Ile93Thr) causing neonatal diabetes mellitus.He died of ketoacidosis. 24941889

2014

dbSNP: rs797045209
rs797045209
0.010 GeneticVariation BEFREE A mutation R1183W was found in the ABCC8 gene encoding SUR1, which was the cause of neonatal diabetes in this case. 20092027

2009

dbSNP: rs80356615
rs80356615
0.010 GeneticVariation BEFREE The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy. 18073297

2008

dbSNP: rs80356618
rs80356618
0.010 GeneticVariation BEFREE We identified KCNJ11 mutations in four of 10 probands with permanent neonatal diabetes and one affected parent; this included the novel C166F mutation and the previously described V59M and R201H. 16670688

2006